908 Devices Inc. (MASS)

US — Healthcare Sector
Peers:   NARI  CNMD  GKOS  NVRO  MDT  MGRM  BFLY  INMD  ABT  SYK  EW  BSX  DXCM 

Automate Your Wheel Strategy on MASS

With Tiblio's Option Bot, you can configure your own wheel strategy including MASS - and automate your put writes, covered calls, and full wheel strategy. Just connect one of the supported brokerages: tastytrade, Schwab, TradeStation or Tradier and go.

Start Your Free Trial Now

Key Metrics & Ratings

  • symbol MASS
  • Rev/Share 1.7356
  • Book/Share 4.5052
  • PB 1.2608
  • Debt/Equity 0.0236
  • CurrentRatio 7.6174
  • ROIC -0.4178

 

  • MktCap 203691616.0
  • FreeCF/Share -1.0108
  • PFCF -5.695
  • PE -11.3647
  • Debt/Assets 0.0192
  • DivYield 0
  • ROE -0.126

 

  • Rating C+
  • Score 2
  • Recommendation Sell
  • P/E Score 1
  • DCF Score 1
  • P/B Score 4
  • D/E Score 4

Recent Analyst Ratings

Type Ticker Analyst Firm Previous Rating Current Rating Previous Price Target Current Price Target Date
No ratings available.

News

Why 908 Devices Stock Rocketed More Than 18% Higher This Week
MASS
Published: May 30, 2025 by: The Motley Fool
Sentiment: Positive

A deal agreed in a far-off country was the spark that ignited chemical analysis device maker 908 Devices (MASS -2.56%) this week. The company's stock burned hot, finishing the period over 18% higher in price, according to data compiled by S&P Global Market Intelligence.

Read More
image for news Why 908 Devices Stock Rocketed More Than 18% Higher This Week
All You Need to Know About 908 Devices (MASS) Rating Upgrade to Buy
MASS
Published: May 26, 2025 by: Zacks Investment Research
Sentiment: Positive

908 Devices (MASS) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

Read More
image for news All You Need to Know About 908 Devices (MASS) Rating Upgrade to Buy
908 Devices Inc. (MASS) Q1 2025 Earnings Call Transcript
MASS
Published: May 13, 2025 by: Seeking Alpha
Sentiment: Neutral

908 Devices Inc. (NASDAQ:MASS ) Q1 2025 Earnings Conference Call May 13, 2025 8:30 AM ET Company Participants Kelly Gura - Investor Relations Kevin Knopp - Chief Executive Officer & Co-Founder Joe Griffith - Chief Financial Officer Conference Call Participants Matt Larew - William Blair Dan Arias - Stifel Puneet Souda - Leerink Partners Brendan Smith - TD Cowen Operator Hello and welcome everyone to the 908 Devices First Quarter 2025 Financial Results Conference Call. My name is Becky [ph] and I'll be your operator today.

Read More
image for news 908 Devices Inc. (MASS) Q1 2025 Earnings Call Transcript
Bet On 4 Low-Beta Stocks BWB, LRN, MASS & PM Despite Tariff Truce
BWB, LRN, MASS, PM
Published: May 13, 2025 by: Zacks Investment Research
Sentiment: Positive

It is imperative to build a portfolio of low-beta stocks in a volatile market. Bridgewater Bancshares, Stride, 908 Devices, and Philip Morris are well-positioned to gain.

Read More
image for news Bet On 4 Low-Beta Stocks BWB, LRN, MASS & PM Despite Tariff Truce
Bet On 4 Low-Beta Stocks BWB, LRN, MASS & PM Despite Tariff Truce
BWB, LRN, MASS, PM
Published: May 13, 2025 by: Zacks Investment Research
Sentiment: Positive

It is imperative to build a portfolio of low-beta stocks in a volatile market. Bridgewater Bancshares, Stride, 908 Devices, and Philip Morris are well-positioned to gain.

Read More
image for news Bet On 4 Low-Beta Stocks BWB, LRN, MASS & PM Despite Tariff Truce
908 Devices Inc. (MASS) Reports Q1 Loss, Misses Revenue Estimates
MASS
Published: May 13, 2025 by: Zacks Investment Research
Sentiment: Negative

908 Devices Inc. (MASS) came out with a quarterly loss of $0.22 per share versus the Zacks Consensus Estimate of a loss of $0.27. This compares to loss of $0.33 per share a year ago.

Read More
image for news 908 Devices Inc. (MASS) Reports Q1 Loss, Misses Revenue Estimates
908 Devices Inc. (MASS) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release
MASS
Published: May 06, 2025 by: Zacks Investment Research
Sentiment: Negative

908 Devices (MASS) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Read More
image for news 908 Devices Inc. (MASS) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release
Buy 4 Low-Beta Stocks ANIP, LRN, MASS & CTGO as Tariff Woes Continue
ANIP, CTGO, LRN, MASS
Published: April 23, 2025 by: Zacks Investment Research
Sentiment: Positive

It is imperative to build a portfolio of low-beta stocks in a volatile market. ANI Pharmaceuticals, Stride, 908 Devices, & Contango are well-poised to gain.

Read More
image for news Buy 4 Low-Beta Stocks ANIP, LRN, MASS & CTGO as Tariff Woes Continue
5 Top-Ranked Stocks of Nasdaq ETF Beating the Bear Market
EZPW, LGTY, MASS, PLMR, TDUP
Published: April 07, 2025 by: Zacks Investment Research
Sentiment: Negative

The tech-focused Nasdaq officially entered bear market territory on Friday, falling over 20% from its December peak.

Read More
image for news 5 Top-Ranked Stocks of Nasdaq ETF Beating the Bear Market
Best Momentum Stocks to Buy for March 13th
BK, MASS, TKOMY
Published: March 13, 2025 by: Zacks Investment Research
Sentiment: Positive

BK, TKOMY and MASS made it to the Zacks Rank #1 (Strong Buy) momentum stocks list on March 13, 2025.

Read More
image for news Best Momentum Stocks to Buy for March 13th
908 Devices Strategic Shift: Desktop Sale To Repligen Optimizes Future Growth
MASS, RGEN
Published: March 04, 2025 by: Benzinga
Sentiment: Positive

On Tuesday, Repligen Corporation RGEN purchased 908 Devices Inc.'s MASS desktop portfolio of four devices for bioprocessing process analytical technology (PAT) applications.

Read More
image for news 908 Devices Strategic Shift: Desktop Sale To Repligen Optimizes Future Growth
908 Devices to Report Fourth Quarter and Full Year 2024 Financial Results on March 4, 2025
MASS
Published: March 03, 2025 by: Business Wire
Sentiment: Neutral

BOSTON--(BUSINESS WIRE)--908 Devices Inc. (Nasdaq: MASS), a pioneer of handheld and desktop devices for chemical analysis, today announced it will report financial results for the fourth quarter and full year 2024 before market open on Tuesday, March 4, 2025. Company management will webcast a corresponding conference call beginning at 8:30 a.m. Eastern Time / 5:30 a.m. Pacific Time. Live audio of the webcast will be available on the “Investors” section of the company website at: www.908devices.

Read More
image for news 908 Devices to Report Fourth Quarter and Full Year 2024 Financial Results on March 4, 2025

About 908 Devices Inc. (MASS)

  • IPO Date 2020-12-18
  • Website https://www.908devices.com
  • Industry Medical - Devices
  • CEO Dr. Kevin J. Knopp Ph.D.
  • Employees 246

908 Devices Inc., a commercial-stage technology company, provides various purpose-built handheld and desktop mass spectrometry (Mass Spec) devices to interrogate unknown and invisible materials in life sciences research, bioprocessing, industrial biotech, forensics, and adjacent markets. The company's products include MX908, a handheld, battery-powered, and Mass Spec device that is designed for rapid analysis of gas, liquid, and solid materials of unknown identity; Rebel, a small desktop analyzer that provides real-time information on the extracellular environment in bioprocesses; and ZipChip solution, a plug-and-play, high-resolution separation platform that optimizes Mass Spec sample analysis. It operates in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. The company was incorporated in 2012 and is headquartered in Boston, Massachusetts.